PreciseMDX Introduces New End-to-End Digital Health Platform that Automates and Simplifies Diagnostic Testing Experience


PreciseMDX, the leading end-to-end digital health platform, introduces a cloud-based solution that automates and simplifies the diagnostic testing experience, empowering labs to deliver a transformative journey to providers and patients. PreciseMDX dramatically improves connectivity between clinical labs, providers, and patients during every step of the diagnostic testing process for any type of test.

Their first-of-its-kind platform enables labs of any size to quickly and seamlessly set up rapidly scalable, personalized, digital experiences that providers and patients expect in this post-pandemic era where consumer adoption of virtual care has skyrocketed. The unexpected volume of COVID-19 testing has exposed the costs and risks associated with manual data management. PreciseMDX replaces manual data entry with an automated flexible end-to-end solution that works seamlessly with any LIS or LIMS, allowing labs to scale their business and streamline workflow, resulting in significant time and cost savings.

Read More

Next Post

Accenture HealthTech Innovation Challenge Names Eight Finalists

Accenture (NYSE: ACN) has named eight companies as finalists in the Accenture HealthTech Innovation Challenge, which brings together leading-edge startups with prominent health companies to tackle some of North America’s greatest health challenges. Attracting more than 2,600 startup applicants in the past five years, the Accenture HealthTech Innovation Challenge supports […]